000 | 01056 a2200301 4500 | ||
---|---|---|---|
005 | 20250518022253.0 | ||
264 | 0 | _c20190502 | |
008 | 201905s 0 0 eng d | ||
022 | _a1862-8354 | ||
024 | 7 |
_a10.1002/prca.201800087 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFrantzi, Maria | |
245 | 0 | 0 |
_aProteomics in Drug Development: The Dawn of a New Era? _h[electronic resource] |
260 |
_bProteomics. Clinical applications _c03 2019 |
||
300 |
_ae1800087 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDrug Discovery _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMass Spectrometry |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aPrecision Medicine |
650 | 0 | 4 |
_aProteomics _xmethods |
700 | 1 | _aLatosinska, Agnieszka | |
700 | 1 | _aMischak, Harald | |
773 | 0 |
_tProteomics. Clinical applications _gvol. 13 _gno. 2 _gp. e1800087 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/prca.201800087 _zAvailable from publisher's website |
999 |
_c29333555 _d29333555 |